Obesity and related parameters of non-alcoholic steatohepatitis.
نویسندگان
چکیده
BACKGROUND/AIMS The aim of this prospective study was to evaluate the clinical, biochemical and histopathological parameters of nonalcoholic steatohepatitis and the conditions associated with this disease. METHODS Twenty-four patients were included in the study, each having been diagnosed with nonalcoholic steatohepatitis on the basis of liver biopsy and elimination of other possible causes of elevated aminotransferase levels. Measurements of degree of obesity, liver enzymes and serum lipids were recorded before liver biopsy and reevaluated after one or two months of a standard exercise and diet program. Serum insulin levels were also measured. Each liver biopsy was histologically examined for steatosis, inflammation, fibrosis, necrosis and iron storage, and semiquantitave assessment of these was recorded for three separate hepatic zones. RESULTS The prevalence of obesity in the group was 79.2%, while the figure for overt and latent diabetes mellitus combined was 33.3%, and for hyperlipidemia was 83.3%. Compared to the rest of the group, the patients with severe steatosis had significantly higher serum lipid (particularly high triglyceride) and insulin levels (p<0.05 for both). There was a correlation between steatosis and obesity (p=0.06). More severe obesity, higher insulin and elevated aspartate aminotransferase were positively correlated with inflammation, whereas elevated serum triglyceride was negatively correlated with inflammation. There was a tendency towards normalization of liver enzyme levels after weight loss and dietary restrictions. CONCLUSIONS Obesity and hyperlipidemia were associated with nonalcoholic steatohepatitis in the group studied. Obesity is not a factor in every case, but the study showed that restricted diet and exercise are significant forms of therapy for nonalcoholic steatohepatitis.
منابع مشابه
Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Background: Pro-inflammatory cytokines are associated with systemic inflammatory responses. Objective: To investigate the levels of pro-inflammatory cytokines (IL-1b, IL-6, and TNF-a) in patients with non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) compared to healthy individuals. Methods: This case-control study was c...
متن کاملPediatric Non-Alcoholic Fatty Liver Disease
The rapidly increasing prevalence of childhood obesity and its associated co-morbidities such as hypertriglyceridemia, hyper-insulinemia, hypertension, early atherosclerosis, metabolic syndrome, and non-alcoholic fatty liver disease are major public health concerns in many countries. Therefore the trends in child and adolescent obesity should be closely monitored over time, as in the near futur...
متن کاملNon-Alcoholic Steatohepatitis and Bariatric Surgery
Non-alcoholic steatohepatitis (NASH) is a component of a wide spectrum of diseases that go from non-alcoholic fatty liver disease (NAFLD) to cirrhosis, and hepatocellular carcinoma in 40-60% of patients with NASH-related cirrhosis in a 5-7 year follow-up [1]. NASH has become one of the leading causes of liver disease in the developed world. With NAFLD believed to have doubled in the past 20 yea...
متن کاملNonalcoholic Steatohepatitis (NASH) — Symptoms and Treatment
Non-alcoholic steatohepatitis, one form of the non-alcoholic fatty liver disease spectrum, has been associated with obesity and lipid dysregulation. The patient usually presents with abnormal lipid and liver profiles. The most evidence based treatment for non-alcoholic steatohepatitis involves around weight loss, glycemic control and avoiding liver insulting drugs. Our current understanding of ...
متن کاملNonalcoholic Steatohepatitis (NASH) — Symptoms and Treatment
Non-alcoholic steatohepatitis, one form of the non-alcoholic fatty liver disease spectrum, has been associated with obesity and lipid dysregulation. The patient usually presents with abnormal lipid and liver profiles. The most evidence based treatment for non-alcoholic steatohepatitis involves around weight loss, glycemic control and avoiding liver insulting drugs. Our current understanding of ...
متن کاملSteatosis and Steatohepatitis: Complex Disorders
Non-alcoholic fatty liver disease (NAFLD) which includes steatosis and steatohepatitis, in particular non-alcoholic steatohepatitis (NASH), is a rising health problem world-wide and should be separated from alcoholic steatohepatitis (ASH). NAFLD is regarded as hepatic manifestation of the metabolic syndrome (MetSy), being tightly linked to obesity and type 2 diabetes mellitus (T2DM). Developmen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
دوره 13 2 شماره
صفحات -
تاریخ انتشار 2002